Skip to main content

Advertisement

SpringerLink
Log in

Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and “First Do No Harm” Part I

  • Prostate Cancer (S Prasad, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To discuss the overall and latest observations of the effect of diet, lifestyle, supplements, and some prescription heart healthy medications for prostate cancer prevention.

Recent Findings

The concept of maximizing heart health to prevent aggressive prostate cancer continues to be solidified with the addition of more prospective observational and randomized controlled trial data. Heart healthy is prostate healthy, but heart unhealthy is prostate unhealthy.

Summary

The primary goal of reducing the risk of all-cause and cardiovascular disease (CVD) morbidity and mortality also allows for maximizing prostate cancer prevention. The obesity epidemic in children and adults along with recent diverse research has only strengthened the nexus between heart and prostate health. Greater dietary adherence toward a variety of healthy foods is associated with a graded improved probability of CVD and potentially aggressive cancer risk reduction. Preventing prostate cancer via dietary supplements should encourage a “first do no harm”, or less is more approach until future evidence can reverse the concerning trend that more supplementation has resulted in either no impact or an increased risk of prostate cancer. Supplements to reduce side effects of some cancer treatments appear to have more encouraging data. Medications that improve heart health including statins, aspirin, and metformin (S.A.M.), and specific beta-blocker medications are primarily generic or low-cost and should continue to garner research interest. A watershed moment in medical education has arrived where the past perception of a diverse number of trees seemingly separated by vast distances, in reality, now appear to exist within the same forest.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016. JAMA. 2018;319:1723–5.

    PubMed  PubMed Central  Google Scholar 

  2. • Ogden CL, Fryar CD, Hales CM, Carroll MD, Aoki Y, Freedman DS. Differences in obesity prevalence by demographics and urbanization in US children and adolescents, 2013–2016. JAMA. 2018;319:2410–8. The updated numbers and distribution of the ongoing obesity epidemic.

    PubMed  Google Scholar 

  3. •• Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137:e67–e492. Arguably, one of the most comprehensive annual summaries of the state of cardiovascular health which includes countless statistics as well as the latest research-based recommendations for you and your patients.

    PubMed  Google Scholar 

  4. Moyad MA. Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part I. Curr Opin Urol. 2005;15:1–6.

    PubMed  Google Scholar 

  5. Moyad MA, Carroll PR. Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention? Urol Clin North Am. 2004;31:301–11.

    PubMed  Google Scholar 

  6. Moyad MA. Lifestyle changes to prevent BPH: heart healthy=prostate healthy. Urol Nurs. 2003;23:439–41.

    PubMed  Google Scholar 

  7. Matthes KL, Pestoni G, Korol D, Van Hemelrijck M, Rohrmann S. The risk of prostate cancer mortality and mortality of nonmetastatic prostate cancer patients: a population-based retrospective cohort study. Urol Oncol. 2018;36:309.e15–23. https://doi.org/10.1016/j.urolonc.2018.02.016.

    PubMed  Google Scholar 

  8. Bourke L, Stevenson R, Turner R, Hooper R, Sasieni P, Greasley R, et al. Exercise training as a novel primary treatment for localized prostate cancer: a multi-site randomized controlled phase II study. Sci Rep. 2018;8:8374. https://doi.org/10.1038/s41598-018-26682-0.

  9. Dickerman BA, Torfadottir JE, Valdimarsdottir UA, Wilson KM, Steingrimsdottir L, Aspelund T, et al. Midlife metabolic factors and prostate cancer risk in later life. Int J Cancer. 2018;142:1166–73.

    PubMed  Google Scholar 

  10. • Moradi S, Issah A, Mohammadi H, Mirzael K. Associations between dietary inflammatory index and incidence of breast and prostate cancer: a systematic review and meta-analysis. Nutrition. 2018;55–56:168–78. Interesting approach of classifying foods based on their ability to reduce inflammatory markers.

    PubMed  Google Scholar 

  11. Ngai HY, Yuen KS, Ng CM, Cheng CH, Chu SP. Metabolic syndrome and benign prostatic hyperplasia: an update. Asian J Androl. 2017;4:164–73.

    Google Scholar 

  12. Masaoka H, Matsuo K, Ito H, Wakai K, Nagata C, Nakayama T, et al. Cigarette smoking and bladder cancer risk: an evaluation based on a systematic review of epidemiologic evidence in the Japanese population. Jpn J Clin Oncol. 2016;46:273–83.

    PubMed  Google Scholar 

  13. Gebild H, Larsen CM, Graugaard C, Areskoug JK. Physical activity to improve erectile function: a systematic review of intervention studies. Sex Med. 2018;6:75–89.

    Google Scholar 

  14. Li D, Xu Y, Nie Q, Mao G. Predictors of urinary incontinence between abdominal obesity and non-obese male adults. Postgrad Med. 2017;129:747–55.

    PubMed  Google Scholar 

  15. Colditz GA, Peterson LL. Obesity and cancer: evidence, impact, and future directions. Clin Chem. 2018;64:154–62.

    CAS  PubMed  Google Scholar 

  16. Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3:280–7.

    PubMed  Google Scholar 

  17. Campi R, Brookman-May SD, Subiela Henriquez JD, Akdogan B, Brausi M, Klatte T, et al. Impact of metabolic diseases, drugs, and dietary factors on prostate cancer risk, recurrence, and survival: a systematic review by the European Association of Urology Section of Oncological Urology. Eur Urol Focus. 2018. https://doi.org/10.1016/j.euf.2018.04.001.

  18. Klaassen Z, Howard LE, Moreira DM, Andriole GL Jr, Terris MK, Freedland SJ. Association of obesity-related hemodilution of prostate-specific antigen, dihydrotestosterone, and testosterone. Prostate. 2017;77(5):466–70.

    CAS  PubMed  Google Scholar 

  19. Gucalp A, Iyengar NM, Zhou XK, Giri DD, Falcone DJ, Wang H, et al. Periprostatic adipose inflammation is associated with high-grade prostate cancer. Prostate Cancer Prostatic Dis. 2017;20:418–23.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Rundle A, Wang Y, Sadasivan S, Chitale DA, Gupta NS, Tang D, et al. Larger men have larger prostates: detection bias in epidemiologic studies of obesity and prostate cancer risk. Prostate. 2017;77:949–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Cardoso L, Rodrigues D, Gomes L, Carrilho F. Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab. 2017;19:1223–32.

    PubMed  Google Scholar 

  22. Mackenzie H, Markar SR, Askari A, Falz O, Hull M, Purkayastha S, et al. Obesity and risk of cancer. Br J Surg. 2018. https://doi.org/10.1002/bjs.10914.

    CAS  PubMed  Google Scholar 

  23. Argolo DF, Hudis CA, Iyengar NM. The impact of obesity on breast cancer. Curr Oncol Rep. 2018;20(6):47. https://doi.org/10.1007/s11912-018-0688-8.

    Article  PubMed  Google Scholar 

  24. GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 392:2018–1035. https://doi.org/10.1016/S0140-6736(18)31310-2.

    Google Scholar 

  25. • Burton R, Sheron N. No level of alcohol consumption improves health. Lancet. 2018. https://doi.org/10.1016/S0140-6736(18)31571-X. One of the largest international studies published on the impact of alcohol and health, which now suggests there is no safe level of intake with this carcinogen.

    Google Scholar 

  26. Scheideler JK, Klein WMP. Awareness of the link between alcohol consumption and cancer across the world: a review. Cancer Epidemiol Biomark Prev. 2018;27:429–37.

    Google Scholar 

  27. Zhao J, Stockwell T, Roemer A, Chikritzhs T. Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta-analysis. BMC Cancer. 2016;16:845.

    PubMed  PubMed Central  Google Scholar 

  28. • Gong Z, Kristal AR, Schenk JM, Tangen CM, Goodman PJ, Thompson IM. Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer. 2009;115:3661–9. The ancillary data on lifestyle being garnered by the PCPT and REDUCE is remarkable and should be reviewed including the potential ability of alcohol to eliminate some of the benefits of these medications.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Fowke JH, Howard L, Andriole GL, Freedland SJ. Alcohol intake increases high-grade prostate cancer risk among men taking dutasteride in the REDUCE trial. Eur Urol. 2014;66:1133–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Parsons JK, Schenk JM, Arnold KB, Messer K, Till C, Thompson IM, et al. Finasteride reduces the risk of incident clinical benign prostatic hyperplasia. Eur Urol. 2012;62:234–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Muller RL, Gerber L, Moreira DM, Andriole G Jr, Hamilton RJ, Fleshner N, et al. Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasteride. Eur Urol. 2013;63:1115–21.

    CAS  PubMed  Google Scholar 

  32. Michael J, Howard LE, Market SC, De Hoedt A, Bailey C, Mucci LA, et al. Early-life alcohol intake and high-grade prostate cancer: results from an equal-access, racially diverse biopsy cohort. Cancer Prev Res (Phila). 2018;11:621–8. https://doi.org/10.1158/1940-6207.CAPR-18-0057.

    Article  Google Scholar 

  33. Battista K, Leatherdale ST. Estimating how extra calories from alcohol consumption are likely an overlooked contributor to youth obesity. Health Promot Chronic Dise Prev Can. 2017;37:194–200.

    Google Scholar 

  34. Butler L, Popkin BM, Poti JM. Associations of alcoholic beverage consumption with dietary intake, waist circumference, and body mass index in US adults: National Health and Nutrition Examination Survey 2003–2012. J Acad Nutr Diet. 2018;118:409–20.

    PubMed  Google Scholar 

  35. Tayie FA, Back GL. Alcoholic beverage consumption contributes to caloric and moisture intakes and body weight status. Nutrition. 2016;32:799–805.

    CAS  PubMed  Google Scholar 

  36. Kim JY, Lee DY, Lee YJ, Park KJ, Kim KH, Kim JW, et al. Chronic alcohol consumption potentiates the development of diabetes through pancreatic beta-cell dysfunction. World J Biol Chem. 2015;6:1–15.

    PubMed  PubMed Central  Google Scholar 

  37. Parsons JK, Im R. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia. J Urol. 2009;182:1463–8.

    PubMed  Google Scholar 

  38. Chow PM, Liu SP, Chuang YC, Lee KS, Yoo TK, Liao L, et al. The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study. World J Urol. 2018. https://doi.org/10.1007/s00345-018-2329-0.

    CAS  PubMed  Google Scholar 

  39. Suh B, Shin DW, Hwang SS, Choi HC, Kwon H, Cho B, et al. Alcohol is longitudinally associated with lower urinary tract symptoms partially via high-density lipoprotein. Alcohol Clin Exp Res. 2014;38:2878–83.

    CAS  Google Scholar 

  40. Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024.

    PubMed  PubMed Central  Google Scholar 

  41. Loftfield E, Cornells MC, Caporaso N, Yu K, Sinha R, Freedman N. Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK Biobank. JAMA Intern Med. 2018;178:1086–97.

    PubMed  Google Scholar 

  42. Hu Y, Ding M, Yuan C, Wu K, Smith-Waner SA, Hu FB, et al. Association between coffee intake after diagnosis of colorectal cancer and reduced mortality. Gastroenterology. 2018;154:916–26.

    PubMed  Google Scholar 

  43. Gapstur SM, Anderson RL, Campbell PT, Jacobs EJ, Hartman TJ, Hildebrand JS, et al. Associations of coffee drinking and cancer mortality in the Cancer Prevention Study-II. Cancer Epidemiol Biomark Prev. 2017;26:1477–86.

    CAS  Google Scholar 

  44. Schmitt SL, Rennert HS, Rennert G, Gruber SB. Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol Biomark Prev. 2016;25:634–9.

    Google Scholar 

  45. Gan Y, Wu J, Zhang S, Li L, Cao S, Mkandawire N, et al. Association of coffee consumption with risk of colorectal cancer: a meta-analysis of prospective cohort studies. Oncotarget. 2017;8:18699–711.

  46. Guercio BJ, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, et al. Coffee intake, recurrence, and mortality in stage III colon cancer: results from CALGB 89803 (Alliance). J Clin Oncol. 2015;33:3598–607.

    PubMed  PubMed Central  Google Scholar 

  47. Allcandro G, Tavani A, La Vecchia C. Coffee and cancer risk: a summary overview. Eur J Cancer Prev. 2017;26:424–32.

    Google Scholar 

  48. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006;12:4018–26.

    CAS  PubMed  Google Scholar 

  49. Pantuck AJ, Pettaway CA, Dreicer R, Corman J, Katz A, Ho A, et al. A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2015;18:242–8.

    CAS  PubMed  Google Scholar 

  50. Stenner-Liewen F, Liewen H, Cathomas R, Renner C, Petrausch U, Sulser T, et al. Daily pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer - results of a phase IIb randomized controlled trial. J Cancer. 2013;4:597–605.

    PubMed  PubMed Central  Google Scholar 

  51. Freedland SJ, Carducci M, Kroeger N, Partin A, Rao JY, Jin Y, et al. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy. Cancer Prev Res (Phila). 2013;6:1120–7.

    CAS  PubMed  Google Scholar 

  52. Auerbach BJ, Littman AJ, Krieger J, Young BA, Larson J, Tinker L, et al. Association of 100% fruit juice consumption and 3-year weight change among postmenopausal women in the Women’s Health Initiative. Prev Med. 2018;109:8–10.

  53. Pan A, Lalik VS, Hao T, Willett WC, Mozaffarian D, Hu FB. Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies. Int J Obes. 2013;37:1378–85.

    CAS  Google Scholar 

  54. Hebden L, O’Leary F, Rangan A, Singgih Lie E, Hirani V, Allman-Farinelli M. Fruit consumption and adiposity status in adults: a systematic review of current evidence. Crit Rev Food Sci Nutr. 2017;57:2526–40.

    PubMed  Google Scholar 

  55. Tapsell LC, Batterham MJ, Thorne RL, O’Shea JE, Grafenauer SJ, Probst YC. Weight loss effects from vegetable intake: a 12-month randomized controlled trial. Eur J Clin Nutr. 2014;68:778–85.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Kaiser KA, Brown AW, Bohan Brown MM, Shikany JM, Mattes RD, Allison DB. Increased fruit and vegetable intake has no discernible effect on weight loss: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100:567–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Obert J, Pearlman M, Obert L, Chapin S. Popular weight loss strategies: a review of four weight loss techniques. Curr Gastroenterol Rep. 2017;19:61.

    PubMed  Google Scholar 

  58. Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomized controlled trials. Br J Nutr. 2013;110:1178–787.

    CAS  PubMed  Google Scholar 

  59. Bradbury KE, Appleby PN, Key TJ. Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr. 2014;100(Suppl 1):394S–8S.

    CAS  PubMed  Google Scholar 

  60. Rowles JL 3rd, Ranard KM, Smith JW, An R, Erdman JW Jr. Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2017;20:361–7.

    CAS  PubMed  Google Scholar 

  61. Chen P, Zhang W, Wang X, Zhao K, Negi DS, Zhuo L, et al. Lycopene and risk of prostate cancer: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e1260.

    CAS  Google Scholar 

  62. Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ, et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 2014;106(2):djt430.

    PubMed  PubMed Central  Google Scholar 

  63. Giovannucci E, Rimm EB, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst. 2002;94:391–8.

    CAS  PubMed  Google Scholar 

  64. Cheng HM, Koutsidis G, Lodge JK, Ashor A, Siervo M, Lara J. Tomato and lycopene supplementation and cardiovascular risk factors: a systematic review and meta-analysis. Atherosclerosis. 2017;257:100–8.

    CAS  PubMed  Google Scholar 

  65. Zhang M, Wang K, Chen L, Tin B, Song Y. Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases. Andrology. 2016;4:745–56.

    CAS  PubMed  Google Scholar 

  66. Petimar J, Wilson KM, Wu K, Wang M, Albanes D, van den Brandt PA, et al. A pooled analysis of 15 prospective cohort studies on the association between fruit, vegetable, and mature bean consumption and risk of prostate cancer. Cancer Epidemiol Biomark Prev. 2017;26:1276–87.

    Google Scholar 

  67. Li J, Mao QQ. Legume intake and risk of prostate cancer: a meta-analysis of prospective cohort studies. Oncotarget. 2017;8:44776–84.

    PubMed  PubMed Central  Google Scholar 

  68. Diallo A, Deschasaux M, Galan P, Hercberg S, Zelek L, Latino-Martel P, et al. Associations between fruit, vegetable and legume intake and prostate cancer risk: results from the prospective Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort. Br J Nutr. 2016;115:1579–85.

    CAS  PubMed  Google Scholar 

  69. Li H, Li J, Shen Y, Wang J, Zhou D. Legume consumption and all-cause and cardiovascular disease mortality. Biomed Res Int. 2017;8450618.

  70. Marventano S, Izquierdo Pulido M, Sanchez-Gonzalez C, Godos J, Speciani A, Galvano F, et al. Legume consumption and CVD risk: a systematic review and meta-analysis. Public Health Nutr. 2017;20:245–54.

    PubMed  Google Scholar 

  71. Kim Y, Je Y. Dietary fibre intake and mortality from cardiovascular disease and all cancers: a meta-analysis of prospective cohort studies. Arch Cardiovasc Dis. 2016;109:39–54.

    PubMed  Google Scholar 

  72. Ndanuko RN, Tapsell LC, Charlton KE, Neale EP, Batterham MJ. Dietary patterns and blood pressure in adults: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2016;7:76–89.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. • Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117–24. A historic first clinical trial in nutritional medicine with a dietary pattern that would ultimately demonstrate that what is heart healthy is indeed healthy from the human body.

    CAS  PubMed  Google Scholar 

  74. Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med. 1999;159:285–93.

    CAS  PubMed  Google Scholar 

  75. Steinberg D, Bennett GG, Svetkey L. The DASH diet, 20 years later. JAMA. 2017;17:1529–153.

    Google Scholar 

  76. Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20:2253–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N, et al. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. Am J Kidney Dis. 2014;63:456–63.

    CAS  PubMed  Google Scholar 

  78. Razavi Zade M, Telkabadi MH, Bahmani F, Salehi B, Farshbaf S, Asemi Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. Liver Int. 2016;36:563–71.

    CAS  PubMed  Google Scholar 

  79. Fleet JC. DASH with the dash (of salt) can lower blood pressure. Nutr Rev. 2001;59:291–3.

    CAS  PubMed  Google Scholar 

  80. Doyle L, Cashman KD. The DASH diet may have beneficial effects on bone health. Nutr Rev. 2004;62:215–20.

    PubMed  Google Scholar 

  81. Dixon LB, Subar AF, Peters U, Weissfeld JL, Bresaller RS, Risch A, et al. Adherence to the USDA food guide, DASH eating plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma. J Nutr. 2007;137:2443–50.

    CAS  PubMed  Google Scholar 

  82. Du M, Liu SH, Mitchell C, Fung TT. Associations between diet quality scores and risk of postmenopausal estrogen receptor-negative breast cancer: a systematic review. J Nutr. 2018;148:100–8.

    PubMed  Google Scholar 

  83. Salas-Salvado J, Becerra-Tomas N, Garcia-Gavilan JF, Bullo M, Barrubes L. Mediterranean diet and cardiovascular disease prevention: what do we know? Prog Cardiovasc Dis. 2018;61:62–7.

    PubMed  Google Scholar 

  84. • Castello A, Boldo E, Amiano P, Castano-Vinyais G, Aragones N, Gomez-Acebo I, et al. Mediterranean dietary pattern is associated with low risk of aggressive prostate cancer: MCC-Spain study. J Urol. 2018;199:430–7. Interesting investigation demonstrating the link between dietary patterns normally associated with cardiovascular health and the potential for simultaneous prostate cancer risk reduction.

    PubMed  Google Scholar 

  85. Reedy J, Krebs-Smith SM, Miller PE, Liese AD, Kahle LL, Park Y, et al. Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults. J Nutr. 2014;144:881–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Brookman-May SD, Campi R, Henriquez JDS, Klatte T, Langenhuijsen JF, Brausi M, et al. Latest evidence of the impact of smoking, sports, and sexual activity as modifiable lifestyle risk factors for prostate cancer incidence, recurrence, and progression: a systematic review of the literature by the European Association of Urology Section of Oncological Urology (ESOU). Eur Urol Focus. 2018. https://doi.org/10.1016/j.euf.2018.02.007.

  87. Foerster B, Pozo C, Abufaraj M, Mari A, Kimura S, D’Andrea D, et al. Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic review and meta-analysis. JAMA Oncol. 2018;4:953–61.

    PubMed  Google Scholar 

  88. De Nunzio C, Andriole GL, Thompson IM Jr, Freedland SJ. Smoking and prostate cancer: a systematic review. Eur Urol Focus. 2015;1:28–38.

    PubMed  Google Scholar 

  89. Noble N, Paul C, Turon H, Oldmeadow C. Which modifiable health risk behaviors are related? A systematic review of the clustering of smoking, nutrition, alcohol, and physical activity (“SNAP”) health risk factors. Prev Med. 2015;81:16–41.

    PubMed  Google Scholar 

  90. • Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2017;35:867–74. A comprehensive overview of lifestyle changes that could impact cancer before and after a diagnosis from some of the leading researchers in the field of nutritional medicine and prostate cancer.

    CAS  PubMed  Google Scholar 

  91. Fiedenreich CM, Wang Q, Nellson HK, Kopcluk KA, McGregor SE, Coumeya KS. Physical activity and survival after prostate cancer. Eur Urol. 2016;70:576–85.

    Google Scholar 

  92. Vainshelbolm B, Muller J, Lima RM, Nead KT, Chester C, Chan K, et al. Cardiorespiratory fitness, physical activity and cancer mortality in men. Prev Med. 2017;100:89–94.

    Google Scholar 

  93. Campos C, Sotomayor P, Jerez D, Gonzalez J, Schmidt CB, Schmidt K, et al. Exercise and prostate cancer: from basic science to clinical applications. Prostate. 2018;78:639–45.

    PubMed  Google Scholar 

  94. • Gorin AA, Lenz EM, Corneilus T, Huedo-Medina T, Wojtanowski AC, Foster GD. Randomized controlled trial examining the ripple effect of a nationally available weight management program on untreated spouses. Obesity (Silver Spring). 2018;26:499–504. A remarkable summary of data in the intervention and control arm of a randomized trial that demonstrates the dramatic potential for a ripple effect to improve spousal health regardless if the family member was assigned to the intervention itself or a control group.

    Google Scholar 

  95. Gacci M, Russo GI, De Nunzio C, Sebastianelli A, Salvi M, Vignozzi L, et al. Meta-analysis of metabolic syndrome and prostate cancer. Prostate Cancer Prostatic Dis. 2017;20:146–55.

    CAS  PubMed  Google Scholar 

  96. • Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137:e30–66. A unique review of the nexus between a common cancer and cardiovascular risk factors, and interestingly the common risk factors among CVD and breast cancer.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Michigan Medical Center, Ann Arbor, MI, USA

    Mark A. Moyad

Authors
  1. Mark A. Moyad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark A. Moyad.

Ethics declarations

Conflict of Interest

Mark A. Moyad Abbie Speakers bureau on Diet Consultant for Farr Labs and max International.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Prostate Cancer

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moyad, M.A. Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and “First Do No Harm” Part I. Curr Urol Rep 19, 104 (2018). https://doi.org/10.1007/s11934-018-0846-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-018-0846-4

Keywords

Search

Navigation